SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-22-000012
Filing Date
2022-01-25
Accepted
2022-01-25 08:00:34
Documents
18
Period of Report
2022-01-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20220125.htm   iXBRL 8-K 47725
2 EX-99.1 a2021q4exhibit991.htm EX-99.1 57217
3 EX-99.2 a2021q4exhibit992.htm EX-99.2 1191744
8 a4q21overallfinancialresul.jpg GRAPHIC 11387
9 a4q21regionalfinancialresu.jpg GRAPHIC 16896
10 a4q21salesbysegment.jpg GRAPHIC 19960
  Complete submission text file 0000200406-22-000012.txt   1627865

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20220125.xsd EX-101.SCH 3338
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20220125_def.xml EX-101.DEF 16780
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20220125_lab.xml EX-101.LAB 34215
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20220125_pre.xml EX-101.PRE 17576
12 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20220125_htm.xml XML 19552
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0102
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 22551147
SIC: 2834 Pharmaceutical Preparations